Table S2. Number of patients in each omics dataset in the validation cohort.
Dataset | LPA | PPA | APA | MPA | SPA | Total |
---|---|---|---|---|---|---|
Pathological classification | 4 | 40 | 68 | 23 | 61 | 196 |
mRNA expression | 2 | 9 | 11 | 5 | 11 | 38 |
LPA, lepidic predominant ADC; PPA, papillary predominant ADC; APA, acinar predominant ADC; MPA, micropapillary predominant ADC; SPA, solid predominant ADC.